HOME >> MEDICINE >> NEWS
SNM collaboration yields diagnostic nuclear medicine guide for compliance with NRC regulations

Reston, VA....The Society of Nuclear Medicine (SNM) announced today the release of a unique, one-stop reference work for diagnostic nuclear medicine professionals who want to bring their departments and institutions into compliance with recently revised federal regulations governing the medical use of byproduct material. Guide for Diagnostic Nuclear Medicine, published by the SNM and authored by Jeffry A. Siegel, PhD, represents the first major joint effort between the Nuclear Regulatory Commission (NRC; Bethesda, MD) and a stakeholder organization whose members' professional practices are regulated by NRC rules.

The new NRC regulations under 10 CFR Part 35 (Medical Use of Byproduct Material) became effective October 24, 2002, and govern the medical use and licensing of byproduct materials across the spectrum of diagnostic practice. The revised rule is intended to be less prescriptive than the current rule. The most significant change, according to Siegel, is "a new emphasis on risk-informed, performance-based approaches that focus not on procedures but on outcomes." Since the first use of nuclear medicine in the United States in the 1940s, more than one-third of a billion doses have been administered to patients, with unparalleled safety and almost no adverse events. In structuring the new regulations, the NRC took this low risk into account by eliminating or decreasing the prescriptiveness of the regulations that apply to diagnostic nuclear medicine. Instead, the NRC is relying on a performance-based approach that emphasizes not a step-by-step adherence to "best practices" but a consistent level of performance outcomes by institutions at which nuclear medicine is practiced.

"With this changed focus, we knew that it would be useful for practitioners to have a stand-alone document that suggests appropriate operating policies and sample procedures for compliance with the revised Part 35 and with other NRC regulations," says Siegel, who is chair of t
'"/>

Contact: Becky Haines
Bhaines@snm.org
703-708-9000
Society of Nuclear Medicine
30-Oct-2002


Page: 1 2 3

Related medicine news :

1. Houston meeting kicks off collaboration to advance cancer research
2. Novartis announces collaboration with Bayer for EMSELEX
3. Call for national collaboration on medical education research
4. Former President George Bush joins leaders from cancer community to announce historic collaboration
5. University of Pittsburgh and French National Institute begin scientific collaboration
6. Nordic collaboration gives new insights into adjuvant chemotherapy
7. UCSD-TCAG collaboration to focus on transformation of genome-based knowledge into health benefits
8. $15 million grant spurs cancer collaboration; M. D. Anderson, University of Puerto Rico
9. UNC Center for AIDS Research database collaboration with SAS also helping patient care
10. NIH-funded UCSD rheumatic diseases center to facilitate collaboration, speed discoveries
11. New rapid anthrax test developed through collaboration between Mayo Clinic and Roche Diagnostics. Test, which provides results in less than one hour, will be made available to United States laboratories

Post Your Comments:
(Date:4/14/2014)... been made in chemotherapy over the past decade, but ... continues to be a major challenge. , Nanotechnology ... the use of nanocarriers, or capsules, that can transport ... body. , The catch? These carriers are tiny, and ...
(Date:4/14/2014)... the 20th century, is currently losing a lot of ... at the University of South Carolina have just reported ... against so-called "superbugs." , Bacteria have been chipping away ... since their first wide-scale use as antibiotics in the ...
(Date:4/14/2014)... web information on colorectal cancer is too difficult for ... appropriate risks to and concerns of patients, a study ... a review of a dozen popular websites, most of ... were written beyond the recommended sixth-grade reading level, while ...
(Date:4/14/2014)... Inc., announced today a publication demonstrating that the company,s ... cells exposed to plasma samples of patients with a ... "TNT003, an inhibitor of the serine protease C1s, prevents ... was published on-line in the journal Blood ...
(Date:4/14/2014)... Child Development Institute have released their new study of ... success in kindergarten. According to FPG,s report, students enrolled ... of learning. , "Children are progressing at an ... than expected for normal developmental growth," said senior scientist ...
Breaking Medicine News(10 mins):Health News:Nano shake-up 2Health News:Penicillin redux: Rearming proven warriors for the 21st century 2Health News:Penicillin redux: Rearming proven warriors for the 21st century 3Health News:Website information on colon cancer too complex, fails to address key concerns 2Health News:Website information on colon cancer too complex, fails to address key concerns 3Health News:Ex vivo efficacy of C1s antibody as Complement inhibitor in cold agglutinin disease 2Health News:Study gives high marks to NC Pre-K program 2
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and distributors ... able to protect their most important business assets, ... ) Because of the highly-competitive ... remains one of the most litigious industry sectors ...
(Date:1/15/2014)... 2014 MultiCell Technologies, Inc. (OTC Bulletin Board: ... application concerning composition of matter, biological targets, mechanism of ... death.  This patent application describes a ... molecules (VSRNAs) which interfere with the basic homeostatic cellular ...
(Date:1/15/2014)... 2014  According to Millennium Research Group (MRG), the ... the United States and European ... expand moderately through 2022, with embolization particles representing ... interest in drug-eluting beads (DEBs) and radioembolization spheres ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
Cached News: